pembrolizumab
merck
['biomarker', 'mds', 'sclc', 'keynote 604']
dr. discusses biomarkers from keynote 604 in #sclc. will t cell inflamed signature or low mmdsc be helpful in identifying patients most likely to benefit? #asco23 
Director of Thoracic Oncology & Developmental Therapeutics @LombardiCancer, Associate Professor @Georgetown, Co-Host Official @IASLC Podcast, #ITYSL, #HereWeGo